
    
      The WeFlow-Arch Moduler Embedded Aorta Arch Stent Graft System first in man study is a
      prospective, single center, single arm trial, which will enroll a total of 8 patients. The
      goal of this study is to evaluate the safety and efficacy of WeFlow-Arch Moduler Embedded
      Aorta Arch Stent Graft System in the treatment of patients with lesions of the aortic arch.
    
  